BRIEF published on 11/19/2025 at 15:53, 11 months 17 days ago The Vanguard Group Discloses Stake in Qualcomm Form 8.3 The Vanguard Group Takeover Code Stock Holdings Qualcomm Incorporated
BRIEF published on 11/19/2025 at 15:52, 11 months 17 days ago The Vanguard Group Discloses Position in American Axle & Manufacturing Holdings Form 8.3 Takeover Code Stake Disclosure Vanguard American Axle
BRIEF published on 11/19/2025 at 15:50, 11 months 17 days ago The Vanguard Group Announces Shareholdings in Avadel Pharmaceuticals Form 8.3 Irish Takeover Panel Vanguard Group Shareholding Avadel Pharmaceuticals
BRIEF published on 11/19/2025 at 15:49, 11 months 17 days ago The Vanguard Group Discloses Position in Mural Oncology Form 8.3 Relevant Securities Irish Takeover Panel The Vanguard Group Mural Oncology
PRESS RELEASE published on 11/19/2025 at 15:48, 11 months 17 days ago Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated The Vanguard Group, Inc. discloses a 10.67% interest in Qualcomm Incorporated. Details of securities transactions provided in Form 8.3 filing Form 8.3 Disclosure Vanguard Group Securities Transactions Qualcomm
PRESS RELEASE published on 11/19/2025 at 15:47, 11 months 17 days ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc. The Vanguard Group, Inc. discloses a 7.47% stake in American Axle & Manufacturing Holdings, Inc. as of 18 November 2025 Manufacturing Vanguard Group Financial Disclosure Stake American Axle
BRIEF published on 11/19/2025 at 15:47, 11 months 17 days ago The Vanguard Group Discloses Position in Dowlais Group plc Form 8.3 Takeover Code Vanguard Group Security Disclosure Dowlais Group
PRESS RELEASE published on 11/19/2025 at 15:45, 11 months 17 days ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc The Vanguard Group, Inc. discloses 5.71% stake in Avadel Pharmaceuticals plc as of 18 November 2025 Irish Takeover Panel Vanguard Group Financial Disclosure Stake Disclosure Avadel Pharmaceuticals
PRESS RELEASE published on 11/19/2025 at 15:44, 11 months 17 days ago Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc The Vanguard Group, Inc. discloses a 1.67% stake in Mural Oncology plc as per Form 8.3 submitted on 18 November 2025 The Vanguard Group, Inc. Form 8.3 Irish Takeover Panel Stake Disclosure Mural Oncology Plc
PRESS RELEASE published on 11/19/2025 at 15:42, 11 months 17 days ago Form 8.3 - The Vanguard Group, Inc.: Dowlais Group plc The Vanguard Group, Inc. discloses a 5.49% interest in Dowlais Group plc's 1p ordinary securities as of 18 November 2025 The Vanguard Group Interest Disclosure 1p Ordinary Securities 5.49% Interest Dowlais Group Plc
Published on 11/06/2026 at 13:00, 4 hours 9 minutes ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 4 hours 39 minutes ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 4 hours 39 minutes ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/06/2026 at 05:15, 11 hours 54 minutes ago Valeo and QNX Unveil A New Smart Camera Platform at CIIE, Secures Multiple Design Wins
Published on 11/06/2026 at 14:50, 2 hours 18 minutes ago New UN guide keeps people in charge of AI in smart cities
Published on 11/06/2026 at 14:45, 2 hours 23 minutes ago Ningbo Consensus on Collaborative Development released at 2026 Global Mayors Dialogue · Ningbo
Published on 11/06/2026 at 14:40, 2 hours 28 minutes ago Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 11/05/2026 at 18:21, 22 hours 47 minutes ago Total number of voting rights and shares making up the share capital at October 31, 2026
Published on 11/05/2026 at 17:45, 23 hours 24 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 11/05/2026 at 17:29, 23 hours 39 minutes ago Notice of exercise of early redemption option of the subordinated note ISIN FR0010406082
